Sandra Wood v. HHS - Influenza, Guillain-Barré Syndrome (GBS), specifically the Miller-Fisher variant (2023)
Case summary [AI summaries can sometimes make mistakes]
Sandra Wood filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered Guillain-Barré Syndrome (GBS), specifically the Miller-Fisher variant, causally related to an adverse reaction to the influenza and tetanus, diphtheria, acellular pertussis (Tdap) vaccines she received on October 28, 2020. The respondent conceded that Ms.
Wood is entitled to compensation, agreeing that her condition is a defined Table injury and that she met all legal prerequisites for compensation. A ruling on entitlement was issued on June 7, 2023.
Subsequently, on July 14, 2023, a decision awarding damages was issued. The respondent proffered an award of $177,076.94, which included $170,000.00 for pain and suffering, $4,940.14 for past unreimbursable expenses, and $2,136.80 for future unreimbursable expenses.
Ms. Wood agreed with this proffered award, and the court granted the lump sum payment.